Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DUX4L27 is a predicted pseudogene in the human genome closely related to the double homeobox 4 (DUX4) gene family[3]. It shares sequence similarity with DUX4, a double homeodomain transcription factor involved in early embryonic gene regulation, but DUX4L27 has not been shown to encode a functional protein or to mediate any known biological or pathological effects[3][1]. Unlike DUX4—which regulates gene activation in development and is implicated in facioscapulohumeral muscular dystrophy and leukemia—DUX4L27 appears to be transcriptionally silent and lacks evidence for physiological relevance or druggability[1][3][7]. In summary, "DUX4L27" is a pseudogene and not a functional molecular target for therapeutic intervention. All clinical and mechanistic data pertain to its active homolog, DUX4, not to DUX4L27.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Double homeobox 4 like 27 pseudogene (DUX4L27).